Skip to search formSkip to main contentSkip to account menu

Interferon beta-1a 0.03 MG Injection [Avonex]

Known as: Avonex 0.03 MG Injection, AVONEX KIT, interferon beta-1a 30 ug in 1 mL INTRAMUSCULAR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [AVONEX] 
National Institutes of Health

Related topics

Related topics

10 relations
Acetic AcidArginine hydrochlorideAvonexInjection

Broader (1)

Interferon beta-1a 0.03 MG Injection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Over the last two decades, patients have relied on the use of self-injectable disease modifying agents for the treatment of… 
2006
2006
Benefit from Beta Interferon in the Treatment of Multiple Sclerosis
2004
2004
Neuropsychologische Leistungsveränderungen bei MS-Patienten unter Immunmodulation mit Interferon-β-1a (AVONEX®)
1998
1998
Treatment of Multiple Sclerosis with the Interferon-βs
Several inteferons (IFNs) have recently been introduced for the treatment of multiple sclerosis (MS). These are IFNβ-1b… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)